You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent renal cell cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • (no location specified)
May 14, 2023

Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Buffalo (radiation, procedure, other)

Completed
  • Recurrent Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • stereotactic body radiation therapy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)

Recruiting
  • Recurrent Renal Cell Carcinoma
  • Renal Cell Carcinoma
  • Sulfur Hexafluoride Lipid Microspheres
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 29, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Rochester, Minnesota
  • +1 more
Jan 12, 2022

Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal

Not yet recruiting
  • Urothelial Carcinoma
  • +7 more
  • Jelmyto (mitomycin) for pyelocalyceal solution
  • (no location specified)
May 22, 2023

Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Chicago (Stereotactic Body

Recruiting
  • Metastatic Renal Cell Cancer
  • +2 more
  • Stereotactic Body Radiation Therapy
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jun 3, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Shanghai, Shanghai, China
    Huadong Hospital Affiliated to Fudan University
Jun 30, 2022

Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

Completed
  • Metastatic Renal Cell Carcinoma
  • +4 more
  • HyperAcute®-Renal (HAR) Immunotherapy
  • Iowa City, Iowa
  • +2 more
Apr 4, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial

Available
  • Urothelial Cancer of Renal Pelvis
  • +5 more
  • Mitomycin for pyelocalyceal solution
  • (no location specified)
Aug 5, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
Jan 3, 2023

Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

Active, not recruiting
  • Advanced Solid Tumors
  • +15 more
  • (no location specified)
Sep 16, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles

Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • AdGMCAIX-transduced autologous dendritic cells
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Jul 28, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +13 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 8, 2022

Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

Recruiting
  • Locally Advanced Renal Pelvis Urothelial Carcinoma
  • +20 more
  • Duarte, California
  • +16 more
Aug 10, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Los Angeles, California
  • +2 more
Jun 28, 2022

Myeloid Derived Suppressor Cells Clinical Assay in Finding

Recruiting
  • Healthy Subject
  • +5 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021

Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,

Terminated
  • Infiltrating Bladder Urothelial Carcinoma
  • +9 more
  • Cytology Specimen Collection Procedure
  • +4 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 15, 2021

Blood and Tissue Samples From Locally Recurrent or Metastatic

Recruiting
  • Localized Renal Pelvis and Ureter Urothelial Carcinoma
  • +10 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2021